Alpertine
Abandoned antipsychotic
From Wikipedia, the free encyclopedia
Alpertine (INN, USAN; developmental code name WIN-31665) is a drug of the pertine group described as an antipsychotic, neuroleptic, and tranqulizer which was never marketed.[1][2][3]
| Clinical data | |
|---|---|
| Other names | WIN31665; WIN-31,665; Win 31665 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H31N3O4 |
| Molar mass | 437.540 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Structurally, it is a substituted tryptamine and a piperazinylethylindole.[4] The drug is closely structurally related to other "pertines" including milipertine, oxypertine, and solypertine, which are also tryptamines and piperazinylethylindoles.[4]
The related drug oxypertine shows high affinity for the serotonin 5-HT2 and dopamine D2 receptors (Ki = 8.6 nM and 30 nM, respectively) and is also known to act as a catecholamine depleting agent.[5][6] Oxypertine, milipertine, and solypertine all antagonize the behavioral effects of tryptamine, a serotonin receptor agonist, and apomorphine, a dopamine receptor agonist, in animals.[5][7] Conversely however, alpertine was not effective, at least at doses of up to 10 mg/kg.[5][7] ortho-Methoxyphenylpiperazine (oMeOPP) has been said to be a metabolite of the related drugs milipertine and oxypertine.[8][9]
Alpertine was first described in the scientific literature by 1971.[1]